首页> 外文期刊>BMC Immunology >An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity
【24h】

An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity

机译:一种优化的IFN-γELISpot测定法,用于对CMV蛋白反应性效应细胞的细胞介导免疫力进行敏感和标准化的监测

获取原文
           

摘要

Background In healthy individuals, Cytomegalovirus (CMV) infection is efficiently controlled by CMV-specific cell-mediated immunity (CMI). Functional impairment of CMI in immunocompromized individuals however can lead to uncontrolled CMV replication and severe clinical complications. Close monitoring of CMV-specific CMI is therefore clinically relevant and might allow a reliable prognosis of CMV disease as well as assist personalized therapeutic decisions. Methods Objective of this work was the optimization and technical validation of an IFN-γ ELISpot assay for a standardized, sensitive and reliable quantification of CMV-reactive effector cells. T-activated? immunodominant CMV IE-1 and pp65 proteins were used as stimulants. All basic assay parameters and reagents were tested and optimized to establish a user-friendly protocol and maximize the signal-to-noise ratio of the ELISpot assay. Results Optimized and standardized ELISpot revealed low intra-assay, inter-assay and inter-operator variability (coefficient of variation CV below 22%) and CV inter-site was lower than 40%. Good assay linearity was obtained between 6 × 104 and 2 × 105 PBMC per well upon stimulation with T-activated? IE-1 (R2?=?0.97) and pp65 (R2?=?0.99) antigens. Remarkably, stimulation of peripheral blood mononuclear cells (PBMC) with T-activated? IE-1 and pp65 proteins resulted in the activation of a broad range of CMV-reactive effector cells, including CD3+CD4+ (Th), CD3+CD8+ (CTL), CD3?CD56+ (NK) and CD3+CD56+ (NKT-like) cells. Accordingly, the optimized IFN-γ ELISpot assay revealed very high sensitivity (97%) in a cohort of 45 healthy donors, of which 32 were CMV IgG-seropositive. Conclusion The combined use of T-activated? IE-1 and pp65 proteins for the stimulation of PBMC with the optimized IFN-γ ELISpot assay represents a highly standardized, valuable tool to monitor the functionality of CMV-specific CMI with great sensitivity and reliability.
机译:背景技术在健康个体中,巨细胞病毒(CMV)感染可通过CMV特异性细胞介导的免疫(CMI)有效控制。然而,免疫功能低下的个体中CMI的功能受损可能导致不受控制的CMV复制和严重的临床并发症。因此,密切监测CMV特异性CMI在临床上是相关的,并且可能允许对CMV疾病进行可靠的预后,并有助于个性化的治疗决策。方法这项工作的目的是针对CMV反应性效应细胞的标准化,灵敏和可靠定量的IFN-γELISpot测定法的优化和技术验证。 T激活?免疫显性CMV IE-1和pp65蛋白用作刺激物。测试和优化了所有基本测定参数和试剂,以建立用户友好的方案,并最大化ELISpot测定的信噪比。结果经过优化和标准化的ELISpot显示,批内,批间和操作员之间的变异性低(变异系数CV低于22%),站点间的变异系数低于40%。经T活化刺激后,每孔PBMC在6×10 4 和2×10 5 PBMC之间具有良好的测定线性。 IE-1(R 2 α=?0.97)和pp65(R 2 α=?0.99)抗原。值得注意的是,用T激活的T细胞刺激外周血单个核细胞(PBMC)。 IE-1和pp65蛋白可激活多种CMV反应性效应细胞,包括CD3 + CD4 + (Th),CD3 + < / sup> CD8 + (CTL),CD3 ? CD56 + (NK)和CD3 + CD56 + (类似于NKT)细胞。因此,经过优化的IFN-γELISpot分析显示,在45名健康供体中,其中32位是CMV IgG血清阳性的,其灵敏度很高(97%)。结论联合使用T激活吗?通过优化的IFN-γELISpot测定法刺激PBMC的IE-1和pp65蛋白代表了高度标准化的宝贵工具,可高度灵敏和可靠地监测CMV特异性CMI的功能。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号